217 related articles for article (PubMed ID: 29637713)
21. Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity.
Al-Ansary GH; Nasr T; Taha H; Fayad W; Mahgoub S
Bioorg Chem; 2021 Feb; 107():104640. PubMed ID: 33485105
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of novel N
Guo L; Ma Q; Chen W; Fan W; Zhang J; Dai B
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):375-387. PubMed ID: 30734606
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
Wang G; Wang F; Cao D; Liu Y; Zhang R; Ye H; Li X; He L; Yang Z; Ma L; Peng A; Xiang M; Wei Y; Chen L
Bioorg Med Chem Lett; 2014 Jul; 24(14):3158-63. PubMed ID: 24863745
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of 2,4-disubstituted quinazoline derivatives with potent anti-angiogenesis activities.
Yu G; Li Z; Tang L; Xiong Q
Molecules; 2014 Jun; 19(7):8916-32. PubMed ID: 24972275
[TBL] [Abstract][Full Text] [Related]
25. Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents.
Cihan-Üstündağ G; Şatana D; Özhan G; Çapan G
J Enzyme Inhib Med Chem; 2016; 31(3):369-80. PubMed ID: 25910087
[TBL] [Abstract][Full Text] [Related]
26. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
27. Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis.
Upadhyay N; Tilekar K; Safuan S; Kumar AP; Schweipert M; Meyer-Almes FJ; Ramaa CS
Bioorg Chem; 2021 Nov; 116():105350. PubMed ID: 34547645
[TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic activity and mechanism of kaurane diterpenoids from Wedelia chinensis.
Huang W; Liang Y; Wang J; Li G; Wang G; Li Y; Chung HY
Phytomedicine; 2016 Mar; 23(3):283-92. PubMed ID: 26969382
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives.
Sreenivasulu R; Reddy KT; Sujitha P; Kumar CG; Raju RR
Bioorg Med Chem; 2019 Mar; 27(6):1043-1055. PubMed ID: 30773423
[TBL] [Abstract][Full Text] [Related]
30. Anti-cancer effects of F16: A novel vascular endothelial growth factor receptor-specific inhibitor.
Rathinavelu A; Alhazzani K; Dhandayuthapani S; Kanagasabai T
Tumour Biol; 2017 Nov; 39(11):1010428317726841. PubMed ID: 29130389
[TBL] [Abstract][Full Text] [Related]
31. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
[TBL] [Abstract][Full Text] [Related]
32. Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model.
Reddy VG; Reddy TS; Jadala C; Reddy MS; Sultana F; Akunuri R; Bhargava SK; Wlodkowic D; Srihari P; Kamal A
Eur J Med Chem; 2019 Nov; 182():111609. PubMed ID: 31445229
[TBL] [Abstract][Full Text] [Related]
33. LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo.
Zhao K; Yuan Y; Lin B; Miao Z; Li Z; Guo Q; Lu N
Gene; 2018 Feb; 642():533-541. PubMed ID: 29196258
[TBL] [Abstract][Full Text] [Related]
34. Phenyl and Diaryl Ureas with Thiazolo[5,4-d]pyrimidine Scaffold as Angiogenesis Inhibitors: Design, Synthesis and Biological Evaluation.
Xue WJ; Deng YH; Yan ZH; Liu JP; Liu Y; Sun LP
Chem Biodivers; 2019 Apr; 16(4):e1800493. PubMed ID: 30688404
[TBL] [Abstract][Full Text] [Related]
35. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
[TBL] [Abstract][Full Text] [Related]
36. Novel VEGFR-2 inhibitors with an N-acylhydrazone scaffold.
Pauli FP; Martins JR; Paschoalin T; Ionta M; Barbosa MLC; Barreiro EJ
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000130. PubMed ID: 32667721
[TBL] [Abstract][Full Text] [Related]
37. Analogue-based design, synthesis and biological evaluation of 3-substituted-(methylenehydrazono)indolin-2-ones as anticancer agents.
Dweedar HE; Mahrous H; Ibrahim HS; Abdel-Aziz HA
Eur J Med Chem; 2014 May; 78():275-80. PubMed ID: 24686014
[TBL] [Abstract][Full Text] [Related]
38. Discovery of 2,4-diarylaminopyrimidine derivatives bearing dithiocarbamate moiety as novel FAK inhibitors with antitumor and anti-angiogenesis activities.
Su Y; Li R; Ning X; Lin Z; Zhao X; Zhou J; Liu J; Jin Y; Yin Y
Eur J Med Chem; 2019 Sep; 177():32-46. PubMed ID: 31129452
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
Zou H; Zhang L; Ouyang J; Giulianotti MA; Yu Y
Eur J Med Chem; 2011 Dec; 46(12):5970-7. PubMed ID: 22019188
[TBL] [Abstract][Full Text] [Related]
40. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.
Wang W; Wang H; Ni Y; Yao Z; Ye L; Tian J
Tumour Biol; 2016 Jul; 37(7):9221-32. PubMed ID: 26768619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]